Larvol Delta - A-Phase-IIIII-Study-to-Evaluate-the-Immunogenicity-and-Safety-and-Efficacy-of-SWIM816-Vaccines-for-SARSCoV2

SW-BIC-213 - Stemirna Therap

SWIM816 - Stemirna Therap

http://clinicaltrials.gov/ct2/show/NCT05911087

Jun 20, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next